Cargando…
Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies
There is a long history of research into body fluid biomarkers in neurodegenerative and neuroinflammatory diseases. However, only a few biomarkers in cerebrospinal fluid (CSF) are being used in clinical practice. Anti-aquaporin-4 antibodies in serum are currently useful for the diagnosis of neuromye...
Autores principales: | Teunissen, Charlotte E., Tumani, Hayrettin, Bennett, Jeffrey L., Berven, Frode S., Brundin, Lou, Comabella, Manuel, Franciotta, Diego, Federiksen, Jette L., Fleming, John O., Furlan, Roberto, Hintzen, Rogier Q., Hughes, Steve G., Jimenez, Connie R., Johnson, Michael H., Killestein, Joep, Krasulova, Eva, Kuhle, Jens, Magnone, Maria-Chiara, Petzold, Axel, Rajda, Cecilia, Rejdak, Konrad, Schmidt, Hollie K., van Pesch, Vincent, Waubant, Emmanuelle, Wolf, Christian, Deisenhammer, Florian, Giovannoni, Gavin, Hemmer, Bernhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195993/ https://www.ncbi.nlm.nih.gov/pubmed/22096631 http://dx.doi.org/10.1155/2011/246412 |
Ejemplares similares
-
Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis
por: Steinacker, Petra, et al.
Publicado: (2011) -
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study
por: Leurs, CE, et al.
Publicado: (2019) -
Cerebrospinal fluid kappa free light chains for the diagnosis of
multiple sclerosis: A consensus statement
por: Hegen, Harald, et al.
Publicado: (2022) -
Neurochemical Biomarkers in patients with COVID-19
por: Tumani, Hayrettin
Publicado: (2023) -
Plasma proteome in multiple sclerosis disease progression
por: Malekzadeh, Arjan, et al.
Publicado: (2019)